MGC Pharmaceuticals to collaborate with RMIT on research initiatives

Company News

by Jessica Amir

MGC Pharmaceuticals Limited (ASX:MXC) has announced it has signed a landmark agreement with the Royal Melbourne Institute of Technology (RMIT) to collaborate on research initiatives.

As part of the Binding Memorandum of Understanding (MOU) the medicinal cannabis company and RMIT plan to establish a world first ‘International Library of Cannabis Medicine'. 

The collaboration also involves the parties developing genetic and breeding programs that effectively treat specific diseases with medicinal cannabis.

They also plan to develop medical grade cannabis products for future clinical studies in Australia.

Shares in MGC Pharmaceuticals Limited (ASX:MXC) are trading steady at 6.2 cents.

Jessica Amir

Finance News Network
Jessica is a senior finance journalist and presents the Market Outlook, Market at Midday and Market Wrap. She also presents ASX company news and interviews CEOs. She joined FNN in January 2017 with six years of broadcast journalism experience. She worked as a journalist and producer with Sky News Business, ABC 1, ABC's The Business and ABC24. She also worked in regional Australia for Prime 7 and WIN News as a TV reporter. In her prior life she worked as a financial planner.